ClinicalTrials.Veeva

Menu

Enterobius Vermicularis and Bruxism in Children

A

Aydin Adnan Menderes University

Status

Completed

Conditions

Bruxism, Sleep

Treatments

Other: Bitestrip

Study type

Observational

Funder types

Other

Identifiers

NCT03833505
2017/003-24.03.2017

Details and patient eligibility

About

Background. Bruxism is an involuntary, non-functional activity of the masticatory system, and is frequently seen in childhood. Bruxism has many aetiologies, like malocclusion, psychological factors, allergies and gastrointestinal disorders.

Aim. To investigate the relationship between Enterobius vermicularis infection and bruxism in children.

Full description

Bruxism has many aetiologies, like occlusal interferences, malocclusion, malnutrition, psychological factors, allergies and gastrointestinal disorders. Among these gastrointestinal disorders, are various intestinal parasitic infections.

Given the controversy surrounding the potential association between bruxism and intestinal parasitic infestations, both important health issues, this study sought to evaluate the relationship between E. vermicularis infection and bruxism in E. vermicularis-positive and E. vermicularis-negative 3-10-year-olds children with bruxism.

Enrollment

26 patients

Sex

All

Ages

3 to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Teeth-grinding at least once a week in the last 3 months before recruitment according to the criteria established by the American Academy of Sleep Medicine (AASM)
  • Angle class I occlusion
  • Mesial step occlusion according to flush terminal plane.

Exclusion criteria

  • Treated with anti-helminthic drugs in the last 2 months before recruitment
  • Drugs used that could affect the central nervous system and prevent sleep (sedatives, anti-depressants, neuroleptics, anti-muscarinics, selective serotonin re-uptake inhibitors)
  • Sleep disorders (snoring, insomnia, obstructive sleep apnoea, restless leg syndrome, sleep-related epilepsy)
  • Psychiatric or neurological disorders
  • Upper respiratory system obstruction (last 15 days),
  • Any systemic disease;
  • Teeth erosion due to internal (reflux) or external (acidic drinks) factors
  • Dermatological problems, associated with the use of BiteStrip (Up2dent, Inc., Pulheim, Germany);
  • Unsuitable skin structure;
  • Previously diagnosed and treated for bruxism;
  • Angle class II or class III occlusion

Trial design

26 participants in 2 patient groups

Group 1,
Description:
E. vermicularis-positive
Treatment:
Other: Bitestrip
Group 2
Description:
E. vermicularis-negative
Treatment:
Other: Bitestrip

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems